Diagnostic methods for vitreoretinal lymphoma: A review of principles and performance

Abstract: Vitreoretinal lymphoma (VRL) poses a significant diagnostic challenge due to its frequent masquerade as chronic uveitis. Timely and accurate diagnosis is essential to guide treatment and prevent death, irreversible vision loss, or central nervous system progression. However, traditional diagnostic methods including cytopathology and immunohistochemistry from vitreous biopsies are often limited by scant cellularity, cellular degeneration, and surgeon dependency. Flow cytometry can detect B-cell clonality and immunophenotypes but similarly depends on viable cells and lacks morphological confirmation, which can lead to misinterpretation in reactive inflammation. To overcome these limitations, molecular techniques are increasingly integrated into diagnostic workflows. Polymerase chain reaction enables the detection of immunoglobulin gene rearrangements or MYD88 mutations from even small intraocular samples, with high specificity and sensitivity. However, diagnostic performance may be compromised in MYD88- negative disease or low tumor burden, and false positives can arise from benign clonal expansions. Metagenomic deep sequencing has emerged as a powerful tool capable of simultaneously detecting infectious agents and a broad range of tumor-associated mutations from minute deoxyribonucleic acid (DNA) inputs, including cell-free DNA. Its unbiased nature makes it particularly useful in diagnostically ambiguous cases, although cost, turnaround time, and data interpretation remain barriers to widespread clinical use. Single-cell sequencing offers the highest resolution to date, enabling the genomic and transcriptomic profiling of individual malignant cells. This allows precise clonal identification, assessment of tumor heterogeneity, and detection of rare or subclonal variants that may inform prognosis or treatment resistance. These approaches significantly enhance VRL diagnostic precision and are poised to redefine current standards of care.

Authors

Institutions

Publication Details

Journal
Taiwan Journal of Ophthalmology
Published
2026-07-17
DOI
https://doi.org/10.4103/tjo.tjo-d-26-00005
Primary Topic
CNS Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic methods for vitreoretinal lymphoma: A review of principles and performance

John A. Gonzales, Thananop Pothikamjorn
Taiwan Journal of Ophthalmology
CNS Lymphoma Diagnosis and Treatment
article

Diagnostic methods for vitreoretinal lymphoma: A review of principles and performance

John A. Gonzales, Thananop Pothikamjorn
article en

Abstract

Abstract: Vitreoretinal lymphoma (VRL) poses a significant diagnostic challenge due to its frequent masquerade as chronic uveitis. Timely and accurate diagnosis is essential to guide treatment and prevent death, irreversible vision loss, or central nervous system progression. However, traditional diagnostic methods including cytopathology and immunohistochemistry from vitreous biopsies are often limited by scant cellularity, cellular degeneration, and surgeon dependency. Flow cytometry can detect B-cell clonality and immunophenotypes but similarly depends on viable cells and lacks morphological confirmation, which can lead to misinterpretation in reactive inflammation. To overcome these limitations, molecular techniques are increasingly integrated into diagnostic workflows. Polymerase chain reaction enables the detection of immunoglobulin gene rearrangements or MYD88 mutations from even small intraocular samples, with high specificity and sensitivity. However, diagnostic performance may be compromised in MYD88- negative disease or low tumor burden, and false positives can arise from benign clonal expansions. Metagenomic deep sequencing has emerged as a powerful tool capable of simultaneously detecting infectious agents and a broad range of tumor-associated mutations from minute deoxyribonucleic acid (DNA) inputs, including cell-free DNA. Its unbiased nature makes it particularly useful in diagnostically ambiguous cases, although cost, turnaround time, and data interpretation remain barriers to widespread clinical use. Single-cell sequencing offers the highest resolution to date, enabling the genomic and transcriptomic profiling of individual malignant cells. This allows precise clonal identification, assessment of tumor heterogeneity, and detection of rare or subclonal variants that may inform prognosis or treatment resistance. These approaches significantly enhance VRL diagnostic precision and are poised to redefine current standards of care.

Taiwan Journal of Ophthalmology
Thai Red Cross Society (TH), Chulalongkorn University (TH), University of California, San Francisco (US), King Chulalongkorn Memorial Hospital (TH), San Francisco Foundation (US)
Good health and well-being
Openalex Percentile: Top 8%
CNS Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.